Allianz Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.3M | Sell |
31,900
-14,000
| -31% | -$14.2M | 0.03% | 497 |
|
|
2025
Q4 | $49.3M | Sell |
45,900
-4,100
| -8% | -$3.92M | 0.05% | 344 |
|
|
2025
Q3 | $38.1M | Sell |
50,000
-10,900
| -18% | -$8.11M | 0.04% | 399 |
|
|
2025
Q2 | $47.5M | Buy |
60,900
+8,700
| +17% | +$6.76M | 0.06% | 336 |
|
|
2025
Q1 | $43.1M | Buy |
52,200
+30,200
| +137% | +$25.1M | 0.06% | 335 |
|
|
2024
Q4 | $17M | Sell |
22,000
-9,100
| -29% | -$7.53M | 0.02% | 590 |
|
|
2024
Q3 | $27.6M | Buy |
31,100
+6,100
| +24% | +$5.48M | 0.04% | 448 |
|
|
2024
Q2 | $22.6M | Buy |
25,000
+24,200
| +3,025% | +$19.4M | 0.03% | 450 |
|
|
2024
Q1 | $622K | Sell |
800
-16,300
| -95% | -$11.6M | ﹤0.01% | 1547 |
|
|
2023
Q4 | $9.97M | Sell |
17,100
-49,100
| -74% | -$28.7M | 0.02% | 686 |
|
|
2023
Q3 | $35.6M | Buy |
66,200
+35,900
| +118% | +$18.5M | 0.06% | 336 |
|
|
2023
Q2 | $14.2M | Sell |
30,300
-1,400
| -4% | -$587K | 0.03% | 556 |
|
|
2023
Q1 | $10.9M | Buy |
31,700
+4,500
| +17% | +$1.52M | 0.02% | 667 |
|
|
2022
Q4 | $9.95M | Buy |
27,200
+9,700
| +55% | +$3.44M | 0.02% | 683 |
|
|
2022
Q3 | $5.66M | Sell |
17,500
-4,100
| -19% | -$1.3M | 0.01% | 847 |
|
|
2022
Q2 | $7M | Buy |
21,600
+3,400
| +19% | +$1.02M | 0.01% | 1003 |
|
|
2022
Q1 | $5.21M | Buy |
18,200
+7,700
| +73% | +$1.98M | ﹤0.01% | 1209 |
|
|
2021
Q4 | $2.9M | Sell |
10,500
-37,900
| -78% | -$9.61M | ﹤0.01% | 1463 |
|
|
2021
Q3 | $11.2M | Buy |
48,400
+27,100
| +127% | +$6.69M | 0.01% | 982 |
|
|
2021
Q2 | $4.89M | Buy |
+21,300
| New | +$4.28M | ﹤0.01% | 1125 |
|
|
2020
Q3 | – | Sell |
-63,300
| Closed | -$10.4M | – | 2158 |
|
|
2020
Q2 | $10.4M | Sell |
63,300
-22,300
| -26% | -$3.42M | 0.01% | 872 |
|
|
2020
Q1 | $11.9M | Sell |
85,600
-6,300
| -7% | -$866K | 0.02% | 777 |
|
|
2019
Q4 | $12.1M | Buy |
91,900
+3,300
| +4% | +$383K | 0.01% | 1032 |
|
|
2019
Q3 | $9.91M | Sell |
88,600
-7,000
| -7% | -$779K | 0.01% | 1122 |
|
|
2019
Q2 | $10.6M | Buy |
95,600
+1,900
| +2% | +$224K | 0.01% | 1171 |
|
|
2019
Q1 | $12.2M | Buy |
93,700
+77,500
| +478% | +$9.42M | 0.01% | 1039 |
|
|
2018
Q4 | $1.88M | Sell |
16,200
-19,700
| -55% | -$2.2M | ﹤0.01% | 1792 |
|
|
2018
Q3 | $3.85M | Sell |
35,900
-6,500
| -15% | -$650K | ﹤0.01% | 1677 |
|
|
2018
Q2 | $3.62M | Buy |
42,400
+5,200
| +14% | +$427K | ﹤0.01% | 1681 |
|
|
2018
Q1 | $2.88M | Sell |
37,200
-186,200
| -83% | -$15M | ﹤0.01% | 1770 |
|
|
2017
Q4 | $18.9M | Sell |
223,400
-5,900
| -3% | -$502K | 0.01% | 1003 |
|
|
2017
Q3 | $19.6M | Buy |
229,300
+64,600
| +39% | +$5.3M | 0.02% | 971 |
|
|
2017
Q2 | $13.6M | Sell |
164,700
-39,100
| -19% | -$3.19M | 0.01% | 1167 |
|
|
2017
Q1 | $17.1M | Buy |
203,800
+12,500
| +7% | +$1M | 0.02% | 1084 |
|
|
2016
Q4 | $14.1M | Buy |
191,300
+71,200
| +59% | +$5.3M | 0.01% | 1204 |
|
|
2016
Q3 | $9.64M | Buy |
120,100
+2,400
| +2% | +$192K | 0.01% | 1341 |
|
|
2016
Q2 | $9.27M | Buy |
117,700
+68,500
| +139% | +$5.16M | 0.01% | 1268 |
|
|
2016
Q1 | $3.54M | Sell |
49,200
-28,200
| -36% | -$2.13M | ﹤0.01% | 1577 |
|
|
2015
Q4 | $6.52M | Buy |
77,400
+22,900
| +42% | +$1.9M | 0.01% | 1244 |
|
|
2015
Q3 | $4.56M | Sell |
54,500
-22,300
| -29% | -$1.88M | 0.01% | 1320 |
|
|
2015
Q2 | $6.41M | Buy |
76,800
+27,000
| +54% | +$2.06M | 0.01% | 1292 |
|
|
2015
Q1 | $3.62M | Sell |
49,800
-24,100
| -33% | -$1.72M | ﹤0.01% | 1340 |
|
|
2014
Q4 | $5.1M | Buy |
73,900
+58,400
| +377% | +$3.94M | 0.01% | 1207 |
|
|
2014
Q3 | $1M | Buy |
+15,500
| New | +$981K | ﹤0.01% | 1667 |
|
Other funds holding LLY
VCM
VPM
Allianz Asset Management's LLY Position: Q1 2026 in Review
Allianz Asset Management increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $78.5M and bringing the position to 504,764 shares worth $464M. The position accounts for 0.49% of the portfolio, ranked #29.
Allianz Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $653M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Allianz Asset Management held 504,764 shares of Eli Lilly worth $464M as of Q1 2026.
- Allianz Asset Management bought 77,425 Eli Lilly shares in Q1 2026, an estimated $78.5M.
- Eli Lilly made up 0.49% of Allianz Asset Management's portfolio in Q1 2026, its #29 holding.
- Allianz Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Eli Lilly position peaked at $653M in Q4 2021.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.